Author:
Suresh Anjana,Kamath Gayathri S.,Latheef Fidha,Sasikumar Greeshma,Panicker Sreejith Parameswara
Publisher
Springer Nature Singapore
Reference203 articles.
1. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP). Nontuberculous Mycobacteria (NTM) Infections.2019
2. Zulu M, Monde N, Nkhoma P, Malama S, Munyeme M. Nontuberculous mycobacteria in humans, animals, and water in Zambia: a systematic review. Front Trop Dis. 2021;2:679501.
3. Blanc SM, Robinson D, Fahrenfeld NL. Potential for nontuberculous mycobacteria proliferation in natural and engineered water systems due to climate change: a literature review. City Environ Interact. 2021;11:100070.
4. Park DW, Kim YJ, Sung YK, Chung SJ, Yeo Y, Park TS, Lee H, Moon JY, Kim SH, Kim TH, Yoon HJ. TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area. Sci Rep. 2022;12(1):4003.
5. Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. 2020;152(3):185.